The success of mRNA-based COVID-19 vaccines has created a significant level of interest in this versatile biomolecule for disease prevention and treatment. While production of these vaccines took place in record time, critical decisions must be made when developing novel mRNA applications to ensure manufacturability, reproducibility, and safety.
This webinar will explore foundational elements of the mRNA manufacturing workflow and strategies to design the right facilities to ensure success. Topics include collaborative approaches to ensure access to high-quality raw materials, application of advanced technologies for manufacturing, options for facility design, and key considerations when leveraging a contract development and manufacturing partner.
In this webinar, you will learn:
- Therapeutic potential of mRNA: COVID-19 and beyond
- How mRNA manufacturing workflows and facility design have a significant impact on reproducibility and performance
- Amptec capabilities to accelerate mRNA development and manufacturing
Pharma and biopharma manufacturing
- mRNA
Doba trvání:1h
Jazyk:English
Relace 1:předložené July 8, 2021
Abyste mohli pokračovat ve čtení, přihlaste se nebo vytvořte účet.
Nemáte účet?